Cassava Sciences Inc (SAVA)

$19.72

-0.17

(-0.85%)

Market is closed - opens 7 PM, 17 Jun 2024

Performance

  • $19.60
    $20.91
    $19.72
    downward going graph

    0.63%

    Downside

    Day's Volatility :6.29%

    Upside

    5.69%

    downward going graph
  • $12.32
    $32.10
    $19.72
    downward going graph

    37.53%

    Downside

    52 Weeks Volatility :61.62%

    Upside

    38.57%

    downward going graph

Returns

PeriodCassava Sciences Inc
3 Months
-3.87%
6 Months
-33.94%
1 Year
-21.48%
3 Years
-73.76%

Highlights

Market Capitalization
914.9M
Book Value
$1.82
Earnings Per Share (EPS)
-2.17
Wall Street Target Price
103.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-33.23%
Return On Equity TTM
-33.9%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
-68.0M
EBITDA
-97.9M
Diluted Eps TTM
-2.17
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.78
EPS Estimate Next Year
0.36
EPS Estimate Current Quarter
-0.46
EPS Estimate Next Quarter
-0.45

Analyst Recommendation

Buy
    87%Buy
    12%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Cassava Sciences Inc(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 422.31%

Current $19.72
Target $103.00

Technicals Summary

Sell

Neutral

Buy

Cassava Sciences Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cassava Sciences Inc
Cassava Sciences Inc
-14.74%
-33.94%
-21.48%
-73.76%
1557.5%
Moderna, Inc.
Moderna, Inc.
12.53%
68.85%
11.73%
-27.96%
820.93%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
4.26%
17.19%
33.13%
94.15%
236.31%
Novo Nordisk A/s
Novo Nordisk A/s
5.81%
46.75%
75.34%
236.98%
458.67%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
11.77%
17.81%
40.49%
145.91%
181.42%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cassava Sciences Inc
Cassava Sciences Inc
NA
NA
NA
-0.78
-0.34
-0.33
NA
1.82
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
30.37
30.37
1.46
44.13
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
49.74
49.74
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
30.88
30.88
0.53
17.09
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cassava Sciences Inc
Cassava Sciences Inc
Buy
$914.9M
1557.5%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$56.6B
820.93%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$113.2B
236.31%
30.37
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$638.1B
458.67%
49.74
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$122.8B
181.42%
30.88
39.46%

Institutional Holdings

  • BlackRock Inc

    6.35%
  • Vanguard Group Inc

    4.91%
  • State Street Corporation

    2.28%
  • Geode Capital Management, LLC

    1.88%
  • Gallacher Capital Management LLC

    1.22%
  • COWEN AND COMPANY, LLC

    1.04%

Company Information

refer to descriptions included in the company's filings with the securities and exchange commission for more information about the company. the company does not intend to update and does not take responsibility for any information published on linkedin.

Organization
Cassava Sciences Inc
Employees
29
CEO
Mr. Remi Barbier
Industry
Pharmaceuticals: Other

FAQs